We identified several AD marker genes (e.g., NKTR, GSTM3, TGFB1, TNFRSF1B, SPP1, and CXCL10) which may provide insights into the shared pathobiology of cognitive dysfunction in COVID-19 and AD. This evidence concerns the gene TGFB1 and Alzheimer disease.